Home › Disorders of Excessive Somnolence › Michigan
Disorders of Excessive Somnolence clinical trials in Michigan
7 studies for Disorders of Excessive Somnolence are looking for participants at sites in Michigan.
Cities in Michigan
A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Revive Research Institute, Southfield
- Clinical Neuropsychology Services, Sterling Heights
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Lansing
- Alkermes Investigational Site, Novi
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Lansing
- Alkermes Investigational Site, Novi
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07502443A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)
- Alkermes Investigational Site, Lansing
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 3, 2026 · NCT07540897A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Lansing
- Alkermes Investigational Site, Sterling Heights
RecruitingPhase 2/3
Ages 18 to 70 · All sexes · Updated Aug 7, 2026 · NCT06767683Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
- Clinical Research Site, Lansing
- Clinical Research Site, Novi
- Clinical Research Site, Southfield
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Jul 24, 2026 · NCT06568367A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Sterling Heights, Michigan, Sterling Heights
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Apr 16, 2026 · NCT07096674From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.